Olivia Ford
Family · New Orleans, LANPI 1952811093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,406 and has fallen 77.5% since, to $317 in 2024.
Across 152 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$342
- UCB, Inc.$341
- AbbVie$302
- AstraZeneca$184
- SK Life Science, Inc.$169
- Lundbeck LLC$163
- plus $2K from 23 others
What the payments were for
- Food & beverage$3,091100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MDD US Operations, LLC | 6 | $342 |
| UCB, Inc. | 17 | $341 |
| AbbVie | 20 | $302 |
| AstraZeneca | 8 | $184 |
| SK Life Science, Inc. | 9 | $169 |
| Lundbeck LLC | 8 | $163 |
| Otsuka America Pharmaceutical, Inc. | 7 | $142 |
| CSL Behring | 4 | $137 |
| Impel Pharmaceuticals Inc. | 7 | $127 |
| Acorda Therapeutics, Inc | 6 | $116 |
| Eisai Inc. | 7 | $113 |
| Neurocrine Biosciences, Inc. | 4 | $109 |
| Neurelis, Inc. | 6 | $101 |
| Kyowa Kirin, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| Supernus Pharmaceuticals, Inc. | 4 | $83 |
| Lilly USA, LLC | 5 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $65 |
| Avanir Pharmaceuticals, Inc. | 3 | $60 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Amneal Pharmaceuticals LLC | 3 | $51 |
| Grifols USA, LLC | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Acadia Pharmaceuticals Inc | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Catalyst Pharmaceuticals, Inc. | 1 | $14 |
| Argenx US, Inc. | 1 | $14 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GOCOVRI$231
How this compares
$3,103 in reported general payments places this provider in the 80th percentile of 3,610 family providers in Louisiana.
Other family in New Orleans
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Amy SchmittNew Orleans$48K
- Eric BabineauxNew Orleans$32K
- Cherie AlbroNew Orleans$29K
- Aimee ScroggsNew Orleans$20K
- Kelly BaquetNew Orleans$18K
- Lori LemoineNew Orleans$17K
- Jennifer GreenheckNew Orleans$15K
- Joseph DefraitesNew Orleans$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.